Literature DB >> 19864983

Peripheral arterial disease: current perspectives and new trends in management.

Farhan Aslam1, Attiya Haque, Joanne Foody, L Veronica Lee.   

Abstract

Peripheral arterial disease (PAD) is defined as an arterial brachial index (ABI) of < or =0.90 in the lower extremities and results from a narrowing of the arteries as a result of progressive atherosclerosis. PAD affects 12-20% of Americans aged 65 years or older; however, most are asymptomatic and many do not seek treatment. Improved awareness and education in both the general population and among health care providers about these modifiable risk factors has the potential to improve general health and decrease morbidity and mortality secondary to atherosclerotic vascular disease.

Entities:  

Mesh:

Year:  2009        PMID: 19864983     DOI: 10.1097/SMJ.0b013e3181bb9ab8

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  12 in total

1.  Contribution of nerve growth factor to upregulation of P2X₃ expression in DRG neurons of rats with femoral artery occlusion.

Authors:  Jiahao Liu; Jialiu David Li; Jian Lu; Jihong Xing; Jianhua Li
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-03       Impact factor: 4.733

2.  Prevalence of combined and noncombined dyslipidemia in an Iranian population.

Authors:  Susan Darroudi; Maryam Saberi-Karimian; Maryam Tayefi; Soheil Arekhi; Ali Motamedzadeh Torghabeh; Seyed Mohammad Reza Seyedzadeh Sani; Mohsen Moohebati; Alireza Heidari-Bakavoli; Mahmoud Ebrahimi; Mahmoud Reza Azarpajouh; Mohammad Safarian; Gordon A Ferns; Habibollah Esmaeili; Mohammad Reza Parizadeh; Naghme Mokhber; Adeleh Mahdizadeh; Ali Asghar Mahmoudi; Amir Hossein Sahebkar; Majid Ghayour-Mobarhan
Journal:  J Clin Lab Anal       Date:  2018-06-21       Impact factor: 2.352

3.  Femoral artery occlusion increases expression of ASIC3 in dorsal root ganglion neurons.

Authors:  Jiahao Liu; Zhaohui Gao; Jianhua Li
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-17       Impact factor: 4.733

4.  Effects of a cognitive-behavioral self-help program on depressed mood for people with peripheral arterial disease.

Authors:  N Garnefski; V Kraaij; E Wijers; J Hamming
Journal:  J Clin Psychol Med Settings       Date:  2013-06

5.  Role of surgical treatment for peripheral arterial disease in endovascular era.

Authors:  Sang Jun Park; Jae Chol Hwang; Hong Rae Cho; Ho Jong Park; Sang Jin Kim; Bong Won Park
Journal:  J Korean Surg Soc       Date:  2013-05-28

6.  MRI of arterial flow reserve in patients with intermittent claudication: feasibility and initial experience.

Authors:  Bas Versluis; Marjolein H G Dremmen; Patty J Nelemans; Joachim E Wildberger; Geert-Willem Schurink; Tim Leiner; Walter H Backes
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

7.  Dynamic contrast-enhanced MRI assessment of hyperemic fractional microvascular blood plasma volume in peripheral arterial disease: initial findings.

Authors:  Bas Versluis; Marjolein H G Dremmen; Patty J Nelemans; Joachim E Wildberger; Geert-Willem Schurink; Tim Leiner; Walter H Backes
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

8.  Functional MRI in peripheral arterial disease: arterial peak flow versus ankle-brachial index.

Authors:  Bas Versluis; Patty J Nelemans; Rutger Brans; Joachim E Wildberger; Geert-Willem Schurink; Tim Leiner; Walter H Backes
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

9.  Trends in risk factors for cardiovascular disease among Iranian adolescents: the Tehran Lipid and Glucose Study, 1999-2008.

Authors:  Firoozeh Hosseini-Esfahani; Ateke Mousavi Nasl Khameneh; Parvin Mirmiran; Arash Ghanbarian; Fereidoun Azizi
Journal:  J Epidemiol       Date:  2011-07-30       Impact factor: 3.211

10.  Prevalence of Dyslipidemia among Elementary School Children in Birjand, East of Iran, 2012.

Authors:  Fatemeh Taheri; Toba Kazemi; Bita Bijari; Kokab Namakin; Mahmoud Zardast; Tayyebeh Chahkandi
Journal:  J Tehran Heart Cent       Date:  2016-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.